With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

The K orean C ollege of H elicobacter and U pper G astrointestinal R esearch first
developed guidelines for the diagnosis and treatment of H elicobacter pylori (H. pylori) …

Abstract The Asia–Pacific Consensus Conference was convened to review and synthesize
the most current information on Helicobacter pylori management so as to update the …

Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …

Helicobacter pylori infection is one of the most common infectious diseases worldwide.
Although the prevalence of H. pylori is gradually decreasing, approximately half of the …

Helicobacter pylori causes a serious bacterial infectious disease, and the expectations of
therapy should reflect this fact. Increasing antibiotic resistance, especially to clarithromycin …

Background: Proton-pump inhibitor (PPI)–based triple therapy is the recommended first-line
treatment for Helicobacter pylori infection. A consensus on treatment duration is lacking …

Background: The success rate of currently recommended 7‐day triple therapy with a PPI
plus amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look …

OBJECTIVES: This study evaluated the efficacy and tolerability of potassium-competitive
acid blocker (P-CAB), a new class of gastric acid inhibitory agents, as first-lineH …

Background: This study was performed to evaluate whether the addition of probiotics to
proton pump inhibitor (PPI)‐based triple therapy increases the likelihood of successful …